CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Two Cases of Acromegaly with Empty Sella Syndrome Treated by Long-Acting Release Octreotide.
Dong Jin Kim, Young Jin Seo, Nam Hoon Kim, Hye Soo Chung, Chai Ryoung Eun, Hye Jung Choi, Hye Sook Kim, Sae Jeong Yang, Juri Park, Hye Jin Yoo, Soo Yeon Park, Yun Jeong Lee, Ohk Hyun Ryu, Kye Won Lee, Hee Young Kim, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi
Endocrinol Metab. 2007;22(2):135-141.   Published online April 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.2.135

Excel Download

Two Cases of Acromegaly with Empty Sella Syndrome Treated by Long-Acting Release Octreotide
Journal of Korean Endocrine Society. 2007;22(2):135   Crossref logo
Link1 Link2 Link3

SAT-469 Empty Sella Making Big Changes: A Case of Acromegaly and Empty Sella Syndrome
Journal of the Endocrine Society. 2019;3(Supplement_1):   Crossref logo
Link1

Menetrier's disease treated with octreotide long-acting release
Gastrointestinal Endoscopy. 2004;60(6):1028-1029   Crossref logo
Link1 Link2

SAT-466 Cases of Acromegaly and Presumed Prolactinoma in Setting of Empty Sella Syndrome: Presentation and Management Implications
Journal of the Endocrine Society. 2019;3(Supplement_1):   Crossref logo
Link1

Long-term therapy with long-acting octreotide (Sandostatin-LAR® ) for the management of acromegaly
Clinical Endocrinology. 1998;48(3):311-316   Crossref logo
Link1 Link2 Link3

Prolactin Secretion in the Empty Sella Syndrome, in Prolactinomas and in Acromegaly
Acta Medica Scandinavica. 2009;209(1-6):397-405   Crossref logo
Link1 Link2

Abstract #234: Acromegaly, Insulinoma, Primary Hyperparathyroidism and Empty Sella Syndrome
Endocrine Practice. 2006;12:57   Crossref logo
Link1 Link2

Efficacy of a slow-release formulation of lanreotide (Autogel®120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
Clinical Endocrinology. 2007;67(4):512-519   Crossref logo
Link1 Link2

Serial follow-up of presurgical treatment using pasireotide long-acting release with or without octreotide long-acting release for naïve active acromegaly
Journal of the Formosan Medical Association. 2016;115(6):475-480   Crossref logo
Link1 Link2

Efficacy of a slow-release formulation of lanreotide (Autogel® 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
Yearbook of Medicine. 2008;2008:560-561   Crossref logo
Link1 Link2